Xiaowei Zhu

The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2.

E. Gilson, Jun Xing, Jing Ye, 2015, American journal of physiology. Cell physiology.

Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma

Xianqun Fan, E. Gilson, S. Ge, 2016, International journal of cancer.

Test anxiety and telomere length: Academic stress in adolescents may not cause rapid telomere erosion

E. Gilson, Jing Ye, Waiian Leong, 2017, Oncotarget.